NCT00757419View on ClinicalTrials.gov

AZD3355 Dose-escalation Study in Healthy Males

PHASE1CompletedINTERVENTIONAL

Enrollment

54

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Reflux Disease

Interventions

DRUG

AZD3355

capsules, oral, single or twice daily dose

DRUG

Placebo

To match dosing of AZD3355

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY